131 related articles for article (PubMed ID: 35302641)
21. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.
Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F
Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558
[TBL] [Abstract][Full Text] [Related]
22. Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.
Kim H; Sin JI
Hum Vaccin Immunother; 2012 Nov; 8(11):1714-21. PubMed ID: 23151450
[TBL] [Abstract][Full Text] [Related]
23. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
Lucas ML; Heller L; Coppola D; Heller R
Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
[TBL] [Abstract][Full Text] [Related]
24. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
25. Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling.
Bowers JS; Nelson MH; Kundimi S; Bailey SR; Huff LW; Schwartz KM; Cole DJ; Rubinstein MP; Paulos CM
Clin Cancer Res; 2015 Jun; 21(11):2546-57. PubMed ID: 25904754
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL
J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557
[TBL] [Abstract][Full Text] [Related]
27. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
[TBL] [Abstract][Full Text] [Related]
28. Hydrogel-based co-delivery of CIK cells and oncolytic adenovirus armed with IL12 and IL15 for cancer immunotherapy.
Du YN; Wei Q; Zhao LJ; Fan CQ; Guo LR; Ye JF; Li Y
Biomed Pharmacother; 2022 Jul; 151():113110. PubMed ID: 35605298
[TBL] [Abstract][Full Text] [Related]
29. Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12.
Lewis ND; Sia CL; Kirwin K; Haupt S; Mahimkar G; Zi T; Xu K; Dooley K; Jang SC; Choi B; Boutin A; Grube A; McCoy C; Sanchez-Salazar J; Doherty M; Gaidukov L; Estes S; Economides KD; Williams DE; Sathyanarayanan S
Mol Cancer Ther; 2021 Mar; 20(3):523-534. PubMed ID: 33443094
[TBL] [Abstract][Full Text] [Related]
30. Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivo.
Qu Y; Chen L; Lowe DB; Storkus WJ; Taylor JL
Mol Ther; 2012 Mar; 20(3):644-51. PubMed ID: 22215017
[TBL] [Abstract][Full Text] [Related]
31. Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression.
Radkevich-Brown O; Piechocki MP; Back JB; Weise AM; Pilon-Thomas S; Wei WZ
Cancer Immunol Immunother; 2010 Mar; 59(3):409-17. PubMed ID: 19730859
[TBL] [Abstract][Full Text] [Related]
32. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
Lucas ML; Heller R
DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
[TBL] [Abstract][Full Text] [Related]
33. Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma.
Paoloni M; Mazcko C; Selting K; Lana S; Barber L; Phillips J; Skorupski K; Vail D; Wilson H; Biller B; Avery A; Kiupel M; LeBlanc A; Bernhardt A; Brunkhorst B; Tighe R; Khanna C
PLoS One; 2015; 10(6):e0129954. PubMed ID: 26091536
[TBL] [Abstract][Full Text] [Related]
34. T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression.
Andersen R; Borch TH; Draghi A; Gokuldass A; Rana MAH; Pedersen M; Nielsen M; Kongsted P; Kjeldsen JW; Westergaard MCW; Radic HD; Chamberlain CA; Hölmich LR; Hendel HW; Larsen MS; Met Ö; Svane IM; Donia M
Ann Oncol; 2018 Jul; 29(7):1575-1581. PubMed ID: 29688262
[TBL] [Abstract][Full Text] [Related]
35. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
36. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
37. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
Daud AI; DeConti RC; Andrews S; Urbas P; Riker AI; Sondak VK; Munster PN; Sullivan DM; Ugen KE; Messina JL; Heller R
J Clin Oncol; 2008 Dec; 26(36):5896-903. PubMed ID: 19029422
[TBL] [Abstract][Full Text] [Related]
38. DNA-Based Delivery of Checkpoint Inhibitors in Muscle and Tumor Enables Long-Term Responses with Distinct Exposure.
Jacobs L; De Smidt E; Geukens N; Declerck P; Hollevoet K
Mol Ther; 2020 Apr; 28(4):1068-1077. PubMed ID: 32101701
[TBL] [Abstract][Full Text] [Related]
39. Intratumoral IL-12 and TNF-alpha-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity.
Sabel MS; Skitzki J; Stoolman L; Egilmez NK; Mathiowitz E; Bailey N; Chang WJ; Chang AE
Ann Surg Oncol; 2004 Feb; 11(2):147-56. PubMed ID: 14761917
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.
Oh E; Choi IK; Hong J; Yun CO
Oncotarget; 2017 Jan; 8(3):4730-4746. PubMed ID: 28002796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
